Inicio・Lista de Acciones・Pacira Pharmaceuticals Inc-DE

Pacira Pharmaceuticals Inc-DE

Cerrado

SectorSanidad

27.59 3.41

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

26.19

Máximo

27.59

Métricas clave
By Trading Economics
Ingresos	1.3M 2.9M
Ventas	-19M 177M
P/B Media del Sector	207.077 68.51
BPA	0.6
Margen de beneficios	1.644
Empleados	825
EBITDA	5M 30M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+17.64% upside

Dividendos
By Acuity
Próximas Ganancias	5 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-40M 1.1B
Apertura anterior	24.18
Cierre anterior	27.59

Noticias sobre sentimiento de mercado

By Acuity

50%

175 / 340 Clasificación en Healthcare

Pacira Pharmaceuticals Inc-DE Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 ago 2026, 19:53 UTC

Pacira Biosciences Inc is higher today, supported by overall market strength and a decline in crude oil prices easing inflation concerns.

3 ago 2026, 20:06 UTC

Pacira Biosciences Inc. shares are higher today, reflecting broader market gains led by major stocks, despite no specific company news identified.

31 jul 2026, 20:02 UTC

Pacira Biosciences Inc's shares are lower today, reaching a session low earlier. The price remains above its 20-day moving average despite the decline.

30 jul 2026, 17:16 UTC

Pacira Biosciences is advancing during Thursday's session, regaining momentum after earlier pulling back from a session high amid broader market optimism.

29 jul 2026, 20:04 UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a decline since Tuesday's close. The stock reached an early high before falling significantly.

28 jul 2026, 19:56 UTC

Event

News

Shares of Pacira Biosciences Inc. are higher, driven by survey findings on orthopedic pain's impact on the workforce and strong interest in non-opioid treatments.

27 jul 2026, 18:51 UTC

Event

News

Pacira Biosciences advances PCRX-201 to commercial manufacturing, allowing patient enrollment in Phase 2 ASCEND study. Shares are higher as investor confidence strengthens.

24 jul 2026, 17:16 UTC

Pacira Biosciences Inc shares are lower today, with no specific news driving the decline. Broader market sentiment is impacted by falling crude oil prices.

22 jul 2026, 18:06 UTC

Pacira Biosciences Inc shares are lower in Wednesday's session, pulling back from earlier gains amid broader market caution and rising crude oil prices.

21 jul 2026, 19:56 UTC

Pacira Biosciences Inc is trading higher, reflecting broader market interest in technology and AI sectors ahead of upcoming earnings reports.

20 jul 2026, 19:46 UTC

Pacira Biosciences Inc shares are trading lower today, having retraced from an earlier high. No specific news was identified to explain the decline.

Comparación entre iguales

Cambio de precio

Pacira Pharmaceuticals Inc-DE previsión

Precio Objetivo

By TipRanks

17.64% repunte

Estimación a 12 Meses

Media 31.67 USD 17.64%

Máximo 38 USD

Mínimo 25 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pacira Pharmaceuticals Inc-DE Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para Pacira Pharmaceuticals Inc-DE Dist en los últimos 3 meses.

Sentimiento

By Acuity

175 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Pacira Pharmaceuticals Inc-DE

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.